Evidence map›Paper›PMID 28924204›Full record

ArticleScientific reports2017

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis.

Phuong Chi Nguyen, Vincent Delorme, Anaïs Bénarouche, Benjamin P Martin, Rishi Paudel, Giri R Gnawali, Abdeldjalil Madani, Rémy Puppo, Valérie Landry, Laurent Kremer and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 3 countries.

Phuong Chi NguyenAix-Marseille Univ, CNRS, EIPL, IMM FR3479, Marseille, France.
Vincent DelormeINSERM U1019 CNRS-UMR 8204, Institut Pasteur de Lille, Université de Lille, 1 rue du Professeur Calmette, Lille, France.
Anaïs BénaroucheAix-Marseille Univ, CNRS, EIPL, IMM FR3479, Marseille, France.
Benjamin P MartinDepartment of Chemistry and Biochemistry, University of Missouri-St. Louis, One University Boulevard, St. Louis, Missouri, 63121, United States.
Rishi PaudelDepartment of Chemistry and Biochemistry, University of Missouri-St. Louis, One University Boulevard, St. Louis, Missouri, 63121, United States.
Giri R GnawaliDepartment of Chemistry and Biochemistry, University of Missouri-St. Louis, One University Boulevard, St. Louis, Missouri, 63121, United States.
Abdeldjalil MadaniAix-Marseille Univ, CNRS, EIPL, IMM FR3479, Marseille, France.
Rémy PuppoAix Marseille Univ, CNRS, Institut de Microbiologie de la Méditerranée FR3479, Plate-forme Marseille Protéomique (MaP), Marseille, France.
Valérie LandryINSERM U1019 CNRS-UMR 8204, Institut Pasteur de Lille, Université de Lille, 1 rue du Professeur Calmette, Lille, France.
Laurent KremerInstitut de Recherche en Infectiologie de Montpellier (IRIM), CNRS, UMR 9004, Université de Montpellier, Montpellier, France.ORCID 0000-0002-6604-4458
Priscille BrodinINSERM U1019 CNRS-UMR 8204, Institut Pasteur de Lille, Université de Lille, 1 rue du Professeur Calmette, Lille, France.ORCID 0000-0003-0991-7344
Christopher D SpillingDepartment of Chemistry and Biochemistry, University of Missouri-St. Louis, One University Boulevard, St. Louis, Missouri, 63121, United States.
Jean-François CavalierAix-Marseille Univ, CNRS, EIPL, IMM FR3479, Marseille, France. jfcavalier@imm.cnrs.fr.ORCID 0000-0003-0864-8314
Stéphane CanaanAix-Marseille Univ, CNRS, EIPL, IMM FR3479, Marseille, France. canaan@imm.cnrs.fr.ORCID 0000-0001-7478-300X
Centre National de la Recherche Scientifique · FRUniversity of Missouri–St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new class of Cyclophostin and Cyclipostins (CyC) analogs have been investigated against Mycobacterium tuberculosis H37Rv (M. tb) grown either in broth medium or inside macrophages. Our compounds displayed a diversity of action by acting either on extracellular M. tb bacterial growth only, or both intracellularly on infected macrophages as well as extracellularly on bacterial growth with very low toxicity towards host macrophages. Among the eight potential CyCs identified, CyC

Indexed as

Antitubercular AgentsOrganophosphorus CompoundsHumansMacrophagesMycobacterium tuberculosisTuberculosisAntitubercular AgentscyclophostinOrganophosphorus Compounds

Identifiers

PMID28924204
PMCPMC5603573
OpenAlexW2754407873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.